V002-8782 Screening compound: 8-(4-chlorobenzoyl)-N-[2-(dimethylamino)ethyl]-4-(4-fluorobenzoyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxamide

V002-8782 Screening compound: 8-(4-chlorobenzoyl)-N-[2-(dimethylamino)ethyl]-4-(4-fluorobenzoyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxamide
V002-8782 Screening compound: 8-(4-chlorobenzoyl)-N-[2-(dimethylamino)ethyl]-4-(4-fluorobenzoyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V002-8782
8-(4-chlorobenzoyl)-N-[2-(dimethylamino)ethyl]-4-(4-fluorobenzoyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V002-8782

Molecular Formula

C26H30ClFN4O4 (C26 H30 ClFN4 O4)

Compound Name

8-(4-chlorobenzoyl)-N-[2-(dimethylamino)ethyl]-4-(4-fluorobenzoyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxamide

IUPAC name

8-(4-chlorobenzoyl)-N-[2-(dimethylamino)ethyl]-4-(4-fluorobenzoyl)-1-oxa-48-diazaspiro[4.5]decane-3-carboxamide

SMILES

CN(C)CCNC(C(COC1(CC2)CCN2C(c(cc2)ccc2Cl)=O)N1C(c(cc1)ccc1F)=O)=O

InChI

InChI=1S/C26H30ClFN4O4/c1-30(2)16-13-29-23(33)22-17-36-26(32(22)25(35)19-5-9-21(28)10-6-19)11-14-31(15-12-26)24(34)18-3-7-20(27)8-4-18/h3-10,22H,11-17H2,1-2H3,(H,29,33)/t22-/m1/s1

InChI Key

MUUUKAMQTZJDOQ-JOCHJYFZSA-N

MDL Number (MFCD)

MFCD19806355

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

517

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.934

Distribution Coefficient, logD

0.518

Water Solubility, LogSw

-3.03

Polar Surface Area

67.974

Acid Dissociation Constant (pKa)

13.80

Base Dissociation Constant (pKb)

8.80

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

42.30

V002-8782 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

Antiviral Library (67538 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V002-8782 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V002-8782?
Check Price and Availability of V002-8782, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V002-8782 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V002-8782
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V002-8782
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V002-8782 available by request